Thermo Fisher to acquire Patheon in $7.2bn deal
Thermo Fisher Scientific announced yesterday that it would buy contract development and manufacturing organisation (CDMO) Patheon for $7.2bn...
List view / Grid view
News
Relocating the EMA: An open letter from EFPIA and Pharma Heads of Research
16 May 2017 | By European Federation of Pharmaceutical Industries and Associations (EFPIA)
The EMA is a world class regulator, whose scientific recommendations are a vital element of the ongoing effort to provide EU citizens with quality medicines
A path toward ending AIDS epidemic in the US by 2025
15 May 2017 | By Niamh Marriott, Junior Editor
A new study describes an ambitious but feasible path toward what may have seemed unachievable just a decade ago: an end to the AIDS epidemic in the US...
Market pressures and inadequate production restrict access to antibiotics
15 May 2017 | By Niamh Marriott, Junior Editor
Antibiotics are becoming more difficult to access, mostly because the drugs are less profitable for manufacturers to produce and market...
Antalis Packaging warns of quality control amid corrugated price hikes
15 May 2017 | By Niamh Marriott, Junior Editor
Antalis Packaging says that it is now more important than ever for companies to be watchful on their corrugated box specification and quality...
Quantum dots to shine bright with ROMIL solvents
12 May 2017 | By ROMIL
ROMIL solvents are helping researchers at the Cavendish Laboratory, the University of Cambridge’s Department of Physics, to develop novel quantum dots which could be used in the next generation of solar panels...
SpeeDx and Thermo Fisher Scientific announce strategic partnership for FDA clearance of molecular diagnostic test
ResistancePlus™ MG Test would bring disease and antibiotic resistance testing for potential “superbug”...
The continuum of HIV care: What does it mean and how is Europe doing?
12 May 2017 | By Niamh Marriott, Junior Editor
From diagnosis of HIV to successful viral suppression: this new ECDC report summarises key findings concerning and the Continuum of HIV Care in Europe...
Alzheimer’s experts call for changes in FDA drug approval standards
12 May 2017 | By Niamh Marriott, Junior Editor
Leading Alzheimer's disease researchers published an analysis urging the FDA to clarify and modernise its approach for approval of Alzheimer's drugs...
St. Jude Children’s Research Hospital to commercialise RSV vaccine
12 May 2017 | By Niamh Marriott, Junior Editor
St. Jude Children’s Research Hospital and the Serum Institute of India will develop & commercialise a vaccine against the respiratory syncytial virus (RSV).
New technology could dramatically shorten diagnosis time of stroke patients
11 May 2017 | By Sarah Wills, Editorial Assistant
An ambitious collaboration between Brainomix, an emerging British business, and Boehringer Ingelheim, one of the world’s largest drug companies, is poised to expedite and improve treatment of stroke, the second biggest killer disease in Europe.
European Medicines Agency’s 2016 annual report published
11 May 2017 | By Niamh Marriott, Junior Editor
EMA's report focuses on key achievements in the areas of medicine evaluation, support to R&D of new and innovative treatments and safety monitoring...
Bioreactors and Fermenters market to reach US $4461 million by 2024
The global Bioreactors and Fermenters Market features a largely consolidated vendor landscape and a low to moderate level of competition, says a new report...
EBMT to upgrade patient registry with Elsevier’s MACRO platform
11 May 2017 | By Niamh Marriott, Junior Editor
The EBM, a non-profit organisation for life-threatening blood cancers and diseases, will implement Elsevier’s MACRO platform to support patient registry...
New Canadian clinical guideline for physicians to reduce use of opioids
10 May 2017 | By Niamh Marriott, Junior Editor
Canadian physicians are being advised to reduce their prescribing of opioid medication to patients with chronic non-cancer pain in a new guideline...
